# Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel

> **NCT01095640** · NA · COMPLETED · sponsor: **Actavis Mid-Atlantic LLC** · enrollment: 1159 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** adapalene 0.3% topical gel

## Key facts

- **NCT ID:** NCT01095640
- **Lead sponsor:** Actavis Mid-Atlantic LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 1159 (ACTUAL)
- **Last updated:** 2010-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01095640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01095640, "Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT01095640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*